The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

The new treatment is painful and expensive ... Last May, a 12-year-old with sickle cell anemia was the first person to receive a new gene therapy to treat the disease. The process is painful ...

Although not guideline-approved, screening for iron deficiency in patients with risk factors could prevent progression to ...

The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study ...

Now that the election is behind us, market watchers are digging into what Trump’s victory could mean for the economy in the coming months. As ...

Patients with symptomatic anaemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood disorder. It impairs the bone marrow's ability to ...